Corcept Therapeutics | CORT - Ebit

Aktienkurs
50.81
Täglich Wechseln
-0.39 -0.76%
Monatlich
17.34%
Jährlich
-28.02%
Q2 Prognose
51.20




Ebit Veränderung Datum
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Alaunos Therapeutics USD -1.19M 148K 2025-09
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Ardelyx USD 5.1M 2.02M 2025-12
Aurora Cannabis CAD -35.79M 8.96M 2025-12
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 3.56B 90M 2026-03
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Esperion Therapeutics USD 85.23M 95.19M 2025-12
J&J USD 6.62B 1.51B 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.18B 118M 2026-03
Novartis USD 4.06B 413M 2025-12
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.99B 340M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
TG Therapeutics USD 34.8M 15.7M 2026-03